Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-PRF with Metronidazole for Moderate Periodontitis
NCT06153706Phase 3Completed
- Start
- Jun 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of metronidazole in periodontitis (2 arms). Primary endpoints: Plaque accumulation at 6 months, Gingival inflammation at 6 months and 4 more. Started Jun 2022; status: completed.
02
Drugs
metronidazole
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT06153706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06153706.